(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are TERACT, ESSO, and PIERRE VAC BSA ACT.

Financial Asset	Price	Change	Updated (EST)
TERACT (TRACT.PA)	1.26	41.33%	2024-03-21 13:24:21
ESSO (ES.PA)	108.90	28.19%	2024-03-21 13:03:25
PIERRE VAC BSA ACT (VACBS.PA)	0.10	18.27%	2024-03-21 13:21:40
BERGENBIO (BGBIO.OL)	0.20	14.68%	2024-03-21 12:26:19
ARGENX SE (ARGX.BR)	373.60	14.5%	2024-03-21 12:05:58
ARRIBATEC GROUP (ARR.OL)	4.20	9.09%	2024-03-21 12:25:51
CLARANOVA (CLA.PA)	2.58	8.18%	2024-03-21 13:01:29
LAVIDE HOLDING (LVIDE.AS)	0.29	8.15%	2024-03-21 12:03:22
BE SEMICONDUCTOR (BESI.AS)	149.00	6.96%	2024-03-21 12:01:02
HYBRID SOFTWARE GR (HYSG.BR)	3.30	6.45%	2024-03-21 12:20:11

The three biggest losers today are SEQUANA MEDICAL, ONWARD MEDICAL, and REDITUS,SGPS.

Financial Asset	Price	Change	Updated (EST)
SEQUANA MEDICAL (SEQUA.BR)	1.39	-36.82%	2024-03-21 12:21:41
ONWARD MEDICAL (ONWD.BR)	4.87	-18.83%	2024-03-21 12:21:13
REDITUS,SGPS (RED.LS)	0.06	-15.38%	2024-03-21 12:24:45
VOW (VOW.OL)	5.80	-10.77%	2024-03-21 12:45:10
NR21 (NR21.PA)	54.00	-9.24%	2024-03-21 13:20:57
EUROAPI (EAPI.PA)	2.39	-7.13%	2024-03-21 13:03:38
NHOA (NHOA.PA)	0.56	-6.67%	2024-03-21 13:20:51
FORSEE POWER (FORSE.PA)	1.55	-6.51%	2024-03-21 13:04:49
BIOTALYS (BTLS.BR)	3.19	-5.9%	2024-03-21 12:06:31
OCEANTEAM (OTS.OL)	1.16	-5.69%	2024-03-21 12:42:06

Winners today

1. TERACT (TRACT.PA)

41.33% Price Change

Teract S.A. operates in retail business in Europe. The company operates through Garden Centre Retailer and Marketer segments. It operates garden centers and pet care shops under the Jardiland, Gamm vert, Delbard, and Jardinerie du Terroir brand names. The company also operates in the fresh, local, and organic produce sector under Frais d'Ici and Bio&Co brands with food outlets. It operates 1,597 stores. The company is based in Paris, France.

CAC 40 ended the session with TERACT jumping 41.33% to €1.26 on Thursday, following the last session’s upward trend. CAC 40 jumped 0.22% to €8,179.72, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, TERACT has a trailing twelve months EPS of €0.62.

PE Ratio

TERACT has a trailing twelve months price to earnings ratio of 2.02. Meaning, the purchaser of the share is investing €2.02 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.98%.

Moving Average

TERACT’s worth is way under its 50-day moving average of €2.60 and way under its 200-day moving average of €4.40.

More news about TERACT.

2. ESSO (ES.PA)

28.19% Price Change

Esso S.A.F. refines, distributes, and markets refined petroleum products in France and internationally. It offers gas, gasoline, kerosene, diesel, and heavy fuel oil; and base oils, finished lubricants, white oils, paraffins, and bitumens. The company also manufactures and sells finished lubricants and greases; and wholesales fuel oil, diesel, non-road diesel, and fuels. In addition, it operates a network of service stations under the Esso and Esso Express brands. The company offers fuels under the Esso brand name and lubricants under the Mobil brand. It markets its products through a network of distributors and resellers, as well as directly to customers. The company was incorporated in 1900 and is headquartered in Nanterre, France. Esso S.A.F. operates as a subsidiary of ExxonMobil France Holding S.A.S.

CAC 40 ended the session with ESSO jumping 28.19% to €108.90 on Thursday while CAC 40 jumped 0.22% to €8,179.72.

Earnings Per Share

As for profitability, ESSO has a trailing twelve months EPS of €-6.99.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.52%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 22.8%, now sitting on 22.19B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ESSO’s stock is considered to be overbought (>=80).

Volatility

ESSO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.04%, a positive 0.51%, and a positive 1.97%.

ESSO’s highest amplitude of average volatility was 1.04% (last week), 1.79% (last month), and 1.97% (last quarter).

Yearly Top and Bottom Value

ESSO’s stock is valued at €108.90 at 21:40 EST, way higher than its 52-week high of €89.50.

More news about ESSO.

3. PIERRE VAC BSA ACT (VACBS.PA)

18.27% Price Change

CAC 40 ended the session with PIERRE VAC BSA ACT jumping 18.27% to €0.10 on Thursday, after consecutive sessions in a row of losses. CAC 40 jumped 0.22% to €8,179.72, following the last session’s downward trend on what was a somewhat up trend trading session today.

More news about PIERRE VAC BSA ACT.

4. BERGENBIO (BGBIO.OL)

14.68% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO jumping 14.68% to €0.20 on Thursday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.52% to €1,310.55, after four successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-0.55.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Volatility

BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.84%, a negative 0.89%, and a positive 4.76%.

BERGENBIO’s highest amplitude of average volatility was 4.50% (last week), 4.89% (last month), and 4.76% (last quarter).

Yearly Top and Bottom Value

BERGENBIO’s stock is valued at kr0.20 at 21:40 EST, way under its 52-week high of kr13.03 and way higher than its 52-week low of kr0.08.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BERGENBIO’s stock is considered to be oversold (<=20).

Moving Average

BERGENBIO’s value is way higher than its 50-day moving average of kr0.13 and way under its 200-day moving average of kr4.18.

More news about BERGENBIO.

5. ARGENX SE (ARGX.BR)

14.5% Price Change

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, France, Canada, the United Kingdom, and Italy. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, pemphigus foliaceus, chronic inflammatory demyelinating polyneuropathy, bullous pemphigoid, and idiopathic inflammatory myopathy; and ENHANZE SC. The company is also developing ARGX-109 and ARGX-116; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; and ARGX-114, an antibody directed against the mesenchymal-epithelial transition factor receptor. In addition, its partnered product candidates include Cusatuzumab for treatment of acute myeloid leukemia; ARGX-115 for the treatment of cancer; and ARGX-112 to treat interleukin-22 receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Staten Biotechnology B.V., and Shire International GmbH. It also has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

BEL 20 ended the session with ARGENX SE jumping 14.5% to €373.60 on Thursday while BEL 20 jumped 2.78% to €3,787.97.

Earnings Per Share

As for profitability, ARGENX SE has a trailing twelve months EPS of €-3.79.

Volatility

ARGENX SE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.61%, a negative 0.64%, and a positive 1.64%.

ARGENX SE’s highest amplitude of average volatility was 1.61% (last week), 1.64% (last month), and 1.64% (last quarter).

More news about ARGENX SE.

6. ARRIBATEC GROUP (ARR.OL)

9.09% Price Change

Arribatec Group ASA, a software and consulting company, provides digital business solutions in Norway, Europe, the Americas, and internationally. The company offers solutions for businesses, including ERP systems, integrations, consulting, health checks, develops, HR and payroll, financial and project planning, bank solutions, and travel and expenses. Its solutions include QualiWare, a management system that structures and visualizes processes, activities, regulations, and requirements; Unit4 solutions; RamBase, an ERP business solution that gives control over the value chain; Power BI solutions; Hypergene, a business management tool; Adra Suite that integrates with other financial systems; Microsoft 365; CatalystOne; and Pagero that ensures compliance with legal and electronic billing requirements. Arribatec Group ASA was incorporated in 1998 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARRIBATEC GROUP jumping 9.09% to €4.20 on Thursday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.52% to €1,310.55, after four successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ARRIBATEC GROUP has a trailing twelve months EPS of kr-1.39.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.94%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARRIBATEC GROUP’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

ARRIBATEC GROUP’s stock is valued at kr4.20 at 21:40 EST, way below its 52-week high of kr6.81 and way above its 52-week low of kr0.30.

More news about ARRIBATEC GROUP.

7. CLARANOVA (CLA.PA)

8.18% Price Change

Claranova SE, a technology company, engages in personalized e-commerce, software publishing, and internet of things (IoT) management in France, the United States, the United Kingdom, Germany, other European countries, and internationally. It operates in three segments: PlanetArt, Avanquest, and myDevices. The PlanetArt segment offers photos, frames, personalized books, and FreePrints mobile applications. The Avanquest segment provides antivirus, ad blocker, cleaning, and optimization tools under the Adaware brand; document management tools under the SodaPDF brand; and photo editor software and applications developed under the inPixio brand. The myDevices segment offers IoT solutions. Claranova SE was incorporated in 1984 and is headquartered in Courbevoie, France.

CAC 40 ended the session with CLARANOVA jumping 8.18% to €2.58 on Thursday, following the last session’s upward trend. CAC 40 jumped 0.22% to €8,179.72, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, CLARANOVA has a trailing twelve months EPS of €-0.23.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CLARANOVA’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

CLARANOVA’s stock is valued at €2.58 at 21:40 EST, way below its 52-week high of €3.05 and way higher than its 52-week low of €1.23.

More news about CLARANOVA.

8. LAVIDE HOLDING (LVIDE.AS)

8.15% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. is based in Amsterdam, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING rising 8.15% to €0.29 on Thursday, after three sequential sessions in a row of losses. AEX-Index jumped 1.73% to €875.42, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.02.

Volatility

LAVIDE HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.00%, a negative 0.67%, and a positive 5.29%.

LAVIDE HOLDING’s highest amplitude of average volatility was 5.70% (last week), 3.62% (last month), and 5.29% (last quarter).

Yearly Top and Bottom Value

LAVIDE HOLDING’s stock is valued at €0.29 at 21:40 EST, under its 52-week high of €0.32 and way higher than its 52-week low of €0.18.

Moving Average

LAVIDE HOLDING’s worth is above its 50-day moving average of €0.27 and higher than its 200-day moving average of €0.27.

More news about LAVIDE HOLDING.

9. BE SEMICONDUCTOR (BESI.AS)

6.96% Price Change

BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries in China, the United States, Malaysia, Ireland, Korea, Taiwan, Thailand, Other Asia Pacific and Europe, and internationally. It operates through three segments: Die Attach, Packaging, and Plating. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. It also provides plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. BE Semiconductor Industries N.V. was incorporated in 1995 and is headquartered in Duiven, the Netherlands.

AEX-Index ended the session with BE SEMICONDUCTOR rising 6.96% to €149.00 on Thursday while AEX-Index jumped 1.73% to €875.42.

Earnings Per Share

As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.23.

PE Ratio

BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 66.82. Meaning, the purchaser of the share is investing €66.82 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.73%.

Moving Average

BE SEMICONDUCTOR’s value is under its 50-day moving average of €149.12 and way above its 200-day moving average of €118.18.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 29, 2024, the estimated forward annual dividend rate is 2.15 and the estimated forward annual dividend yield is 1.52%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

BE SEMICONDUCTOR’s EBITDA is 18.99.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BE SEMICONDUCTOR’s stock is considered to be overbought (>=80).

More news about BE SEMICONDUCTOR.

10. HYBRID SOFTWARE GR (HYSG.BR)

6.45% Price Change

Hybrid Software Group PLC, together with its subsidiaries, develops software and hardware technology solutions for graphics and industrial inkjet printing in the United Kingdom, rest of Europe, North and South America, and Asia. The company offers Harlequin Core, a raster image processor (RIP) software that converts text and image data from various file formats, including PDF, TIFF, and JPEG files; ScreenPro, a software that converts tone image data into ready-to-print halftone in real-time; and Mako SDK, a software that creates, rasterizes, converts, analyses, and optimizes various page description languages, as well as allows print software developers to control over colour, fonts, text, images, vector content, and metadata. It also provides Harlequin Direct, a software that drives print data directly to the printer electronics instead of buffering them on mass storage devices; SmartDFE, a turnkey digital front end based on Harlequin Direct, CLOUDFLOW, and Meteor for digital printing of labels and packaging; Navigator Harlequin RIP and Workflow, a software that offers prepress environments to interpretation of PostScript, PDF, and EPS format files; Navigator DFE, a software that helps to prepare jobs, manage colour, and control digital output devices built with Memjet or any standard inkjet printhead; and Output Device Interfaces, a hardware and software solutions to connect RIPs to computer-to-plate devices, imagesetters, proofers, digital presses, high-speed copiers, and inkjet printers. The company was formerly known as Global Graphics PLC and changed its name to Hybrid Software Group PLC in October 2021. Hybrid Software Group PLC was founded in 1986 and is headquartered in Cambridge, the United Kingdom.

BEL 20 ended the session with HYBRID SOFTWARE GR rising 6.45% to €3.30 on Thursday, following the last session’s upward trend. BEL 20 rose 2.78% to €3,787.97, after two consecutive sessions in a row of gains, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, HYBRID SOFTWARE GR has a trailing twelve months EPS of €0.02.

PE Ratio

HYBRID SOFTWARE GR has a trailing twelve months price to earnings ratio of 165. Meaning, the purchaser of the share is investing €165 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.54%.

Volatility

HYBRID SOFTWARE GR’s last week, last month’s, and last quarter’s current intraday variation average was 1.80%, 0.08%, and 2.36%.

HYBRID SOFTWARE GR’s highest amplitude of average volatility was 2.68% (last week), 2.87% (last month), and 2.36% (last quarter).

More news about HYBRID SOFTWARE GR.

Losers Today

1. SEQUANA MEDICAL (SEQUA.BR)

-36.82% Price Change

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL sliding 36.82% to €1.39 on Thursday, following the last session’s downward trend. BEL 20 jumped 2.78% to €3,787.97, after two sequential sessions in a row of gains, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SEQUANA MEDICAL’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

SEQUANA MEDICAL’s stock is valued at €1.39 at 21:40 EST, way under its 52-week low of €2.01.

Moving Average

SEQUANA MEDICAL’s worth is way under its 50-day moving average of €3.10 and way below its 200-day moving average of €3.16.

More news about SEQUANA MEDICAL.

2. ONWARD MEDICAL (ONWD.BR)

-18.83% Price Change

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.

BEL 20 ended the session with ONWARD MEDICAL sliding 18.83% to €4.87 on Thursday while BEL 20 jumped 2.78% to €3,787.97.

Earnings Per Share

As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -69.93%.

More news about ONWARD MEDICAL.

3. REDITUS,SGPS (RED.LS)

-15.38% Price Change

Reditus, Sociedade Gestora de Participações Sociais, S.A., through its subsidiaries, provides business process outsourcing, IT outsourcing, and IT consulting services in Portugal and internationally. The company offers client services, including client, financial, human resource, doc, and facilities management, as well as other business process services; and IT infrastructure services and solutions in the areas of advisory, design, installation, and maintenance of systems and solutions, storage, network, and security. It also provides specialized outsourcing services in the areas of application development and maintenance, DBs and system administration, business intelligence and applications, telecom engineering and networks, and support and helpdesk; and information security services and solutions, as well as security managed services. In addition, the company offers enterprise content management services, solutions, and products for deployment of projects in scanning, document management, and workflow in multi-channel topologies; lean management services and solutions in practical application of diagnostic methodologies; and management and IT consulting services and solutions. Further, it is involved in the development, management, and maintenance of software applications and analytical solutions; and provision of cooperation and development services and solutions in the areas of corporate procurement, project management, and economic and social development, as well as training and personal development services. The company serves public, health, telecom, media, utilities, financial services, consumer, retail, and transportation sectors. The company was founded in 1966 and is headquartered in Lisbon, Portugal.

PSI ended the session with REDITUS,SGPS falling 15.38% to €0.06 on Thursday, after two consecutive sessions in a row of losses. PSI rose 0.43% to €6,178.82, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, REDITUS,SGPS has a trailing twelve months EPS of €0.18.

PE Ratio

REDITUS,SGPS has a trailing twelve months price to earnings ratio of 0.31. Meaning, the purchaser of the share is investing €0.31 for every euro of annual earnings.

Moving Average

REDITUS,SGPS’s value is way higher than its 50-day moving average of €0.04 and way above its 200-day moving average of €0.03.

Volume

Today’s last reported volume for REDITUS,SGPS is 49007 which is 1707.71% above its average volume of 2711.

Volatility

REDITUS,SGPS’s last week, last month’s, and last quarter’s current intraday variation average was 14.17%, 1.67%, and 13.23%.

REDITUS,SGPS’s highest amplitude of average volatility was 14.17% (last week), 16.33% (last month), and 13.23% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, REDITUS,SGPS’s stock is considered to be oversold (<=20).

More news about REDITUS,SGPS.

4. VOW (VOW.OL)

-10.77% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. It operates in three segments: Projects Cruise, Aftersales, and Landbased. The Projects Cruise segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables; chemicals; and tailor-made service and maintenance programs. The Landbased segment offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. This segment also develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. The company serves cruise, aquaculture, and landbased industries, as well as utilities. It has a strategic partnership agreement with Repsol, S.A. to explore applications and solutions to produce clean and renewable energy for CO2 emission reduction; European Tyre Enterprise Ltd. to develop a modularised and industrial solutions, and value chain to turn end-of-life tires into raw material and renewable energy; GRTgaz to produce a demo plant built to confirm that CO2 neutral pyrolysis gas can replace fossil gas in the European gas grid; SAS IMPROVE to develop technological solutions for the farm to fork valorisation of future proteins; and Imtech Steri's Biosteam to offer a range of ingredient sterilisation solutions and services. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW dropping 10.77% to €5.80 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.52% to €1,310.55, after four consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr0.05.

PE Ratio

VOW has a trailing twelve months price to earnings ratio of 116. Meaning, the purchaser of the share is investing kr116 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.1%.

Volume

Today’s last reported volume for VOW is 375894 which is 185.15% above its average volume of 131822.

Revenue Growth

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 918.5M for the twelve trailing months.

More news about VOW.

5. NR21 (NR21.PA)

-9.24% Price Change

NR21 Société Anonyme does not have significant operations. Previously, it was involved in design and distribution of underwear and indoor clothing for men, women, and children. The company is based in Paris, France.

CAC 40 ended the session with NR21 dropping 9.24% to €54.00 on Thursday, following the last session’s downward trend. CAC 40 rose 0.22% to €8,179.72, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, NR21 has a trailing twelve months EPS of €0.51.

PE Ratio

NR21 has a trailing twelve months price to earnings ratio of 105.88. Meaning, the purchaser of the share is investing €105.88 for every euro of annual earnings.

More news about NR21.

6. EUROAPI (EAPI.PA)

-7.13% Price Change

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the composition of drugs for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.

CAC 40 ended the session with EUROAPI dropping 7.13% to €2.39 on Thursday, following the last session’s downward trend. CAC 40 rose 0.22% to €8,179.72, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, EUROAPI has a trailing twelve months EPS of €0.32.

PE Ratio

EUROAPI has a trailing twelve months price to earnings ratio of 7.45. Meaning, the purchaser of the share is investing €7.45 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.62%.

Volatility

EUROAPI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.58%, a negative 5.82%, and a positive 3.91%.

EUROAPI’s highest amplitude of average volatility was 7.02% (last week), 7.68% (last month), and 3.91% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROAPI’s stock is considered to be overbought (>=80).

Moving Average

EUROAPI’s value is way below its 50-day moving average of €5.58 and way below its 200-day moving average of €7.98.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.1%, now sitting on 1.02B for the twelve trailing months.

More news about EUROAPI.

7. NHOA (NHOA.PA)

-6.67% Price Change

NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.

CAC 40 ended the session with NHOA sliding 6.67% to €0.56 on Thursday, following the last session’s upward trend. CAC 40 rose 0.22% to €8,179.72, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, NHOA has a trailing twelve months EPS of €-0.39.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.96%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 88.6%, now sitting on 273.35M for the twelve trailing months.

Volume

Today’s last reported volume for NHOA is 205572 which is 100% above its average volume of 102782.

More news about NHOA.

8. FORSEE POWER (FORSE.PA)

-6.51% Price Change

Forsee Power Société anonyme, together with its subsidiaries, engages in the design, manufacture, assemble, and supply of lithium-based battery systems for mobility applications in France, Europe, Asia, the United States, and internationally. It operates in two segments: Heavy Vehicles, and Light Vehicles and Industrial Tech. The company's products are used in the field of autonomy and mobility for applications in bicycles, scooters, rolling stock, medical facilities, home automation, professional tools, etc.; electric transport for applications in buses, trucks, trams, shipping and rail transport, and marine and offshore vessels; and storage of electrical energy for residential, commercial, and industrial market applications. The company was incorporated in 2007 and is headquartered in Ivry-sur-Seine, France.

CAC 40 ended the session with FORSEE POWER falling 6.51% to €1.55 on Thursday, following the last session’s upward trend. CAC 40 rose 0.22% to €8,179.72, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, FORSEE POWER has a trailing twelve months EPS of €-0.61.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.61%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FORSEE POWER’s stock is considered to be oversold (<=20).

Volatility

FORSEE POWER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.35%, a negative 1.62%, and a positive 1.92%.

FORSEE POWER’s highest amplitude of average volatility was 3.22% (last week), 3.49% (last month), and 1.92% (last quarter).

Yearly Top and Bottom Value

FORSEE POWER’s stock is valued at €1.55 at 21:40 EST, way under its 52-week low of €2.56.

Revenue Growth

Year-on-year quarterly revenue growth grew by 58.4%, now sitting on 140.05M for the twelve trailing months.

More news about FORSEE POWER.

9. BIOTALYS (BTLS.BR)

-5.9% Price Change

Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

BEL 20 ended the session with BIOTALYS sliding 5.9% to €3.19 on Thursday, following the last session’s upward trend. BEL 20 rose 2.78% to €3,787.97, after two sequential sessions in a row of gains, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, BIOTALYS has a trailing twelve months EPS of €-0.76.

Volume

Today’s last reported volume for BIOTALYS is 31272 which is 15.88% above its average volume of 26986.

More news about BIOTALYS.

10. OCEANTEAM (OTS.OL)

-5.69% Price Change

Oceanteam ASA operates as a subsea and offshore services company in Europe. It provides equipment for offshore cable laying, umbilical installations, and on- and offshore storage and transport. The company also rents turntables, tensioners, reels, demountable turntable systems, and other cable handling and storage equipment, as well as offers cable and umbilical storage, and handling solutions. It serves renewable energy, and oil and gas industries. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Bærum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM dropping 5.69% to €1.16 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.52% to €1,310.55.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.62%.

Moving Average

OCEANTEAM’s value is way below its 50-day moving average of kr1.34 and way below its 200-day moving average of kr1.50.

Volatility

OCEANTEAM’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.99%, a negative 0.95%, and a positive 5.20%.

OCEANTEAM’s highest amplitude of average volatility was 5.46% (last week), 5.35% (last month), and 5.20% (last quarter).

Yearly Top and Bottom Value

OCEANTEAM’s stock is valued at kr1.16 at 21:40 EST, way under its 52-week high of kr2.01 and higher than its 52-week low of kr1.10.

More news about OCEANTEAM.

Stay up to date with our winners and losers daily report